Takara Bio Inc. announced that it has reached a distribution agreement with Nippi Inc. to distribute recombinant Laminin 511-E8 fragments (iMatrix-511), which will become available for sale in Japan on July 16th, 2013. The product will be also supplied outside Japan through Takara Bio's sales network.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,370 JPY | -2.72% | -1.29% | -9.90% |
1st Jan change | Capi. | |
---|---|---|
-9.90% | 101M | |
+20.87% | 8.71B | |
+8.05% | 7.81B | |
+12.95% | 6.69B | |
-4.42% | 3.78B | |
-5.81% | 3.77B | |
+2.08% | 1.41B | |
-26.15% | 1.13B | |
+24.00% | 1.07B | |
-11.23% | 906M |
- Stock Market
- Equities
- 7932 Stock
- News Nippi,Incorporated
- Takara Bio Inc. Reaches Distribution Agreement with Nippi Inc